Skip to main content
. Author manuscript; available in PMC: 2014 Apr 15.
Published in final edited form as: Int J Cancer. 2012 Oct 25;132(8):1860–1867. doi: 10.1002/ijc.27872

Fig. 1.

Fig. 1

Magnetic resonance imaging of MN-EPPT accumulation in the mammary fat pads of transgenic MMT or MUC1 control mice. A. MRI. Representative color-coded T2 maps of mice (MUC1 and MMT) injected i.v. with MN-EPPT (10 mg/kg iron). There was a progressive loss of signal intensity (T2 shortening) between non-cancer (MUC1), premalignancy (8-wk MMT) and malignancy (15-wk MMT) in the mammary fat pads (outlined). B. Quantitative analysis of the T2 relaxation times, revealing that these differences are significant (p<0.05).